2-Me-PVP cas: 850352-54-4

CAS NO: 850352-54-4
Chemical Profile of 2-Me-PVP
Chemical Name: 2-Methyl-alpha-PVP
CAS Number: 850352-54-4
Description Review
Description
Within the dynamic realm of synthetic cathinones, 2-Me-PVP has gained attention, especially from researchers and academic circles. This article will offer a thorough examination of its chemical features, possible effects, and safety concerns.




Popular Search Terms on Google
Research on 2-Me-PVP,
850352-54-4 is the chemical compound I'm referring to
Pharmacology of 2-Me-PVP:
Analysis of designer drugs,
Safety profile of 2-Me-PVP:
Researching compounds with stimulating properties,
Exploring the neurochemical effects of 2-Me-PVP
Legal status of 2-Me-PVP:
Exploring different cathinones.
Other products in the same market

Similarities exist between 2-Me-PVP and other synthetic cathinones such as alpha-PVP and MDPV, which are well-known for their stimulant properties and extensive scientific application.

Exploring the Advantages and Possible Impacts
2-Me-PVP is a study drug that is mostly looked at for its ability to stimulate the brain. Its possible health advantages, however, have not been tested on humans and are thus still considered speculative.

Explanation of Product Mechanism
One of the factors that contributes to the stimulant effects of 2-Me-PVP is the fact that it is thought to operate as a dopamine and norepinephrine reuptake inhibitor. This mechanism is like other cathinones and amphetamines.


Ensuring Safety and Addressing Potential Side Effects
Concerns about the safety of 2-Me-PVP have not been fully answered. Possible adverse effects include agitation, elevated heart rate, and an increased risk of addiction—all of which are often linked to stimulants.


Information on Dosage
There is no recognized dosage information for 2-Me-PVP. It is not recommended for use outside of controlled research environments due to the unknown potency and effects.


Warnings
The stimulant properties and unclear profile of 2-Me-PVP make it an unsafe drug to take for anybody with a history of cardiovascular disease, drug addiction, or mental illness.

In summary
In the field of synthetic cathinones, 2-Me-PVP is a prominent area of study that has been taken into consideration. Despite having noticeable stimulant effects, this chemical should be used with extreme care due to the absence of thorough safety and pharmacological evidence. More study is needed to fully realize its potential and comprehend its hazards.


Additional Questions

Q: Can 2-Me-PVP be utilized for medical applications?
The answer is no, 2-Me-PVP is not used in medicine. Clinical trials and safety data are not available for this substance, which is classified as a research chemical.

Q: What are the potential dangers of using 2-Me-PVP?
Just like other stimulant medicines, there is a considerable danger of addiction and misuse, as well as possible cardiovascular difficulties and neurological repercussions.

Q: Is it possible to legally purchase 2-Me-PVP?
2-Me-PVP is allowed in different places. In many countries, the purchase and use of this substance is limited, despite the fact that it is often classified as a research chemical.

  1. 2-Me-PVP effects,
  2. Synthetic cathinones,
  3. 2-Methyl-alpha-PVP,
  4. Designer drugs 2021,
  5. Stimulant drug research,
  6. 2-Me-PVP legality,
  7. Dopamine reuptake inhibitors,
  8. Novel psychoactive substances,
  9. 2-Me-PVP safety profile,
  10. Cathinone class stimulants.
Review
Review

ver_code
1/3
X
Send your message to us
please select your country
  • Afghanistan
  • Aland Islands
  • Albania
  • Algeria
  • American Samoa
  • Andorra
  • Angola
  • Anguilla
  • Antigua and Barbuda
  • Argentina
  • Armenia
  • Aruba
  • Australia
  • Austria
  • Azerbaijan
  • Bahamas
  • Bahrain
  • Bangladesh
  • Barbados
  • Belarus
  • Belgium
  • Belize
  • Benin
  • Bermuda
  • Bhutan
  • Bolivia
  • Bosnia and Herzegovina
  • Botswana
  • Bouvet Island
  • Brazil
  • British Indian Ocean Territory
  • British Virgin Islands
  • Brunei Darussalam
  • Bulgaria
  • Burkina Faso
  • Burundi
  • Cambodia
  • Cameroon
  • Canada
  • Cape Verde
  • Caribbean Netherlands
  • Cayman Islands
  • Central African Republic
  • Chad
  • Chile
  • China
  • Christmas Island
  • Cocos Islands
  • Colombia
  • Comoros
  • Congo
  • Cook Islands
  • Costa Rica
  • Cote D'ivoire
  • Cuba
  • Curaçao
  • Cyprus
  • Czech Republic
  • Democratic People's Republic of Korea
  • Democratic Republic of the Congo
  • Denmark
  • Djibouti
  • Dominica
  • East Timor
  • Ecuador
  • Egypt
  • El Salvador
  • Equatorial Guinea
  • Eritrea
  • Estonia
  • Ethiopia
  • Falkland Islands
  • Faroe Islands
  • Fiji
  • Finland
  • France
  • French Guiana
  • French Polynesia
  • French Southern Territories
  • Gabon
  • Gambia
  • Georgia
  • Germany
  • Ghana
  • Gibraltar
  • Greece
  • Greenland
  • Grenada
  • Guadeloupe
  • Guam
  • Guatemala
  • Guernsey
  • Guinea
  • Guinea-Bissau
  • Guyana
  • Haiti
  • Heard Island and Mcdonald Islands
  • Honduras
  • Hong Kong, China
  • Hungary
  • Iceland
  • India
  • Indonesia
  • Iran
  • Iraq
  • Ireland
  • Isle of Man
  • Israel
  • Italy
  • Jamaica
  • Japan
  • Jordan
  • Kazakhstan
  • Kenya
  • Kiribati
  • Korea
  • Kosovo
  • Kuwait
  • Kyrgyzstan
  • Laos
  • Latvia
  • Lebanon
  • Lesotho
  • Liberia
  • Liechtenstein
  • Lithuania
  • Luxembourg
  • Macau, China
  • Macedonia
  • Madagascar
  • Malawi
  • Malaysia
  • Maldives
  • Mali
  • Malta
  • Marshall Islands
  • Martinique
  • Mauritania
  • Mauritius
  • Mayotte
  • Mexico
  • Micronesia
  • Moldova
  • Monaco
  • Mongolia
  • Montenegro
  • Montserrat
  • Morocco
  • Mozambique
  • Myanmar
  • Namibia
  • Nauru
  • Nepal
  • Netherlands
  • Netherlands Antilles
  • New Caledonia
  • New Zealand
  • Nicaragua
  • Niger
  • Nigeria
  • Niue
  • Norfolk Island
  • Northern Mariana Islands
  • Norway
  • Oman
  • Pakistan
  • Palau
  • Palestine
  • Panama
  • Papua New Guinea
  • Paraguay
  • Peru
  • Philippines
  • Pitcairn Islands
  • Poland
  • Portugal
  • Puerto Rico
  • Qatar
  • Reunion
  • Romania
  • Russia
  • Rwanda
  • Saint Barthélemy
  • Saint Helena
  • Saint Kitts and Nevis
  • Saint Lucia
  • Saint Martin
  • Saint Pierre and Miquelon
  • Saint Vincent and the Grenadines
  • San Marino
  • Sao Tome and Principe
  • Saudi Arabia
  • Senegal
  • Serbia
  • Seychelles
  • Sierra Leone
  • Singapore
  • Sint Maarten
  • Slovakia
  • Slovenia
  • Solomon Islands
  • Somalia
  • South Africa
  • South Georgia and The South Sandwich Islands
  • Spain
  • Sri Lanka
  • State of Libya
  • Sudan
  • Suriname
  • Svalbard and Jan Mayen
  • Swaziland
  • Sweden
  • Switzerland
  • Syrian Arab Republic
  • TaiWan, China
  • Tajikistan
  • Tanzania
  • Thailand
  • The Republic of Croatia
  • Togo
  • Tokelau
  • Tonga
  • Trinidad and Tobago
  • Tunisia
  • Turkey
  • Turkmenistan
  • Turks and Caicos Islands
  • Tuvalu
  • Uganda
  • Ukraine
  • United Arab Emirates
  • United Kingdom
  • United States
  • United States Minor Outlying Islands
  • Uruguay
  • US Virgin Islands
  • Uzbekistan
  • Vanuatu
  • Vatican City State
  • Venezuela
  • Vietnam
  • Wallis and Futuna Islands
  • Western Sahara
  • Western Samoa
  • Yemen
  • Zambia
  • Zimbabwe
ver_code